BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Third Harmonic Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-16 6:49 pm Sale |
2025-04-14 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,372,933![]() (Position Closed) |
Filing |
2024-11-12 5:27 pm Sale |
2024-11-07 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 2,372,933 5.300% |
-1,993,000![]() (-45.65%) |
Filing |
2022-12-21 4:40 pm Purchase |
2022-12-19 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 4,365,933 10.800% |
864,119![]() (+24.68%) |
Filing |
2022-09-26 4:57 pm Purchase |
2022-09-15 | 13G | Third Harmonic Bio, Inc. THRD |
BIOTECHNOLOGY VALUE FUND L P | 3,501,814 9.100% |
3,501,814![]() (New Position) |
Filing |